ArticleJournal of family medicine and primary care2024

SEMAGLUTIDE: Weight loss, glycaemic control and safety profile in obese patients with and without type-II diabetes-An experience from Karachi, Pakistan.

Muhammad Y Memon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.